BNP Paribas Financial Markets’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AGRX
VF
IA
ASN
SM
BNP Paribas Financial Markets's AGRX Position: Q4 2022 in Review
BNP Paribas Financial Markets sold out of Agile Therapeutics (AGRX) in Q4 2022, closing a stake of 1 share — an estimated $13 sold.
BNP Paribas Financial Markets first reported a position in AGRX in Q3 2015 and held it in 11 quarters. The position peaked at $55.1K in Q3 2020. 26 funds tracked by Wall St. Rank hold AGRX as of Q4 2022.
- BNP Paribas Financial Markets reported no remaining Agile Therapeutics position as of Q4 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1 Agile Therapeutics share in Q4 2022, an estimated $13.
- BNP Paribas Financial Markets first reported a position in Agile Therapeutics in Q3 2015 and held it in 11 quarters.
- BNP Paribas Financial Markets's Agile Therapeutics position peaked at $55.1K in Q3 2020.
- 26 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.